UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gastric cancer

The Lancet (British edition), 2016-11, Vol.388 (10060), p.2654-2664

2016

Volltextzugriff (PDF)

Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12109

2022

Volltextzugriff (PDF)

Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (3), p.659-670

2018

Volltextzugriff (PDF)

The Value of Magnetic Resonance Imaging for Radiotherapy Planning

Seminars in radiation oncology, 2014-07, Vol.24 (3), p.151-159

2014

Volltextzugriff (PDF)

Value of Diffusion-Weighted Magnetic Resonance Imaging for Prediction and Early Assessment of Response to Neoadjuvant Radiochemotherapy in Rectal Cancer: Preliminary Results

International journal of radiation oncology, biology, physics, 2012-02, Vol.82 (2), p.863-870

2012

Volltextzugriff (PDF)

Hedgehog signaling in prostate cancer and its therapeutic implication

International Journal of Molecular Sciences, 2013-07, Vol.14 (7), p.13979-14007

2013

Volltextzugriff (PDF)

Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics

Radiotherapy and oncology, 2020-01, Vol.142, p.246-252

2020

Volltextzugriff (PDF)

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis

Radiotherapy and oncology, 2014-01, Vol.110 (1), p.3-8

2014

Volltextzugriff (PDF)

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

European urology, 2013-03, Vol.63 (3), p.450-458

2013

Volltextzugriff (PDF)

Radiation Therapy Oncology Group Consensus Panel Guidelines for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Head Cancer

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (3), p.901-908

2012

Volltextzugriff (PDF)

Image guidance in radiation therapy for better cure of cancer

Molecular oncology, 2020-07, Vol.14 (7), p.1470-1491

2020

Volltextzugriff (PDF)

Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology

Journal of magnetic resonance imaging, 2013-06, Vol.37 (6), p.1392-1401

2013

Volltextzugriff (PDF)

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study

Annals of surgical oncology, 2011-08, Vol.18 (8), p.2224-2231

2011

Volltextzugriff (PDF)

Early and late toxicity of radiotherapy for rectal cancer

Recent results in cancer research, 2014, Vol.203, p.189

2014

Volltextzugriff (PDF)

Validation and IMRT/VMAT delivery quality of a preconfigured fast‐rotating O‐ring linac system

Medical physics (Lancaster), 2019-01, Vol.46 (1), p.328-339

2019

Volltextzugriff (PDF)

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4450-4456

2010

Volltextzugriff (PDF)

Current practice in proton therapy delivery in adult cancer patients across Europe

Radiotherapy and oncology, 2022-02, Vol.167, p.7-13

2022

Volltextzugriff (PDF)

Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial

Trials, 2011-12, Vol.12 (1), p.255-255, Article 255

2011

Volltextzugriff (PDF)

The Benefits of Including Clinical Factors in Rectal Normal Tissue Complication Probability Modeling After Radiotherapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (3), p.1233-1242

2012

Volltextzugriff (PDF)

Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer

Medical physics (Lancaster), 2018-05, Vol.45 (5), p.2205-2217

2018

Volltextzugriff (PDF)

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo

Oncotarget, 2016-12, Vol.7 (51), p.84286-84298

2016

Volltextzugriff (PDF)

Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

EJNMMI research, 2021-04, Vol.11 (1), p.41-10, Article 41

2021

Volltextzugriff (PDF)

1 – 25 von 363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(349)
Mit Volltextzugriff
(316)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(251)
Humans
(212)
Oncology
(191)
Radiology, Nuclear Medicine & Medical Imaging
(131)
Male
(127)
Middle Aged
(77)
Aged
(76)
Radiotherapy
(69)
Prostate Cancer
(63)
Female
(55)
Hematology, Oncology And Palliative Medicine
(52)
Tumors
(45)
Prostatic Neoplasms - Pathology
(42)
Prostatic Neoplasms - Radiotherapy
(42)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Treatment Outcome
(41)
Adult
(37)
Radiation Therapy
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Gastric cancer

Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect

Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation

The Value of Magnetic Resonance Imaging for Radiotherapy Planning

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients

Value of Diffusion-Weighted Magnetic Resonance Imaging for Prediction and Early Assessment of Response to Neoadjuvant Radiochemotherapy in Rectal Cancer: Preliminary Results

Hedgehog signaling in prostate cancer and its therapeutic implication

Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

Radiation Therapy Oncology Group Consensus Panel Guidelines for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Head Cancer

Image guidance in radiation therapy for better cure of cancer

Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study

Early and late toxicity of radiotherapy for rectal cancer

Validation and IMRT/VMAT delivery quality of a preconfigured fast‐rotating O‐ring linac system

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Current practice in proton therapy delivery in adult cancer patients across Europe

Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial

The Benefits of Including Clinical Factors in Rectal Normal Tissue Complication Probability Modeling After Radiotherapy for Prostate Cancer

Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo

Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

Suchergebnisse filtern